NCT00032396
Unknown
Phase 2
A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration
Control Delivery Systems1 site in 1 countryNovember 2001
ConditionsMacular Degeneration
DrugsRetisert Implant
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Macular Degeneration
- Sponsor
- Control Delivery Systems
- Locations
- 1
- Last Updated
- 19 years ago
Overview
Brief Summary
A study evaluating Retisert in patients with age-related macular degeneration
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 3
Improving Function in Age-Related Macular DegenerationAge-Related Macular DegenerationNCT00572039Thomas Jefferson University241
Terminated
Phase 2
Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With RanibizumabAge-Related Macular DegenerationNCT01402544University of California, San Diego20
Completed
Not Applicable
Research on age-related macular degeneration and diabetic complications using non-invasive AGEs measurement equipment.age-related macular degeneration, diabetic retinopathyJPRN-UMIN000010741Shinshu University Graduate School of Medicine, Department of Ophthalmology500
Completed
Phase 3
Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin TrialAge Related Macular DegenerationNCT00593450University of Pennsylvania1,208
Completed
Phase 2
Research Study in Patients With Persistent Macular EdemaDiabetesMacular EdemaDiabetic RetinopathyRetinal DiseaseUveitis, PosteriorNCT00035906Allergan315